CID 71622431

Ivarmacitinib

Structural Information

Molecular Formula
C18H22N8O2S
SMILES
CN(C1C[C@@H]2CN(C[C@@H]2C1)C(=O)NC3=NC(=NS3)OC)C4=NC=NC5=C4C=CN5
InChI
InChI=1S/C18H22N8O2S/c1-25(15-13-3-4-19-14(13)20-9-21-15)12-5-10-7-26(8-11(10)6-12)18(27)23-17-22-16(28-2)24-29-17/h3-4,9-12H,5-8H2,1-2H3,(H,19,20,21)(H,22,23,24,27)/t10-,11+,12?
InChIKey
DNBCBAXDWNDRNO-FOSCPWQOSA-N
Compound name
(3aR,6aS)-N-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

13
References

1225
Patents

414.15863 Da
Monoisotopic Mass

2.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 415.16591 189.0
[M+Na]+ 437.14785 197.3
[M-H]- 413.15135 196.8
[M+NH4]+ 432.19245 201.2
[M+K]+ 453.12179 195.1
[M+H-H2O]+ 397.15589 181.9
[M+HCOO]- 459.15683 202.6
[M+CH3COO]- 473.17248 198.3
[M+Na-2H]- 435.13330 184.5
[M]+ 414.15808 193.5
[M]- 414.15918 193.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe